Trade with your broker
Market capitalisation, EUR | 220,500.92 m |
EPS, EUR | 7.96 |
P/B ratio | 4.81 |
P/E ratio | 12.08 |
Dividend yield | 3.07% |
Revenue, EUR | 42,031.24 m |
Net income, EUR | 7,925.26 m |
Profit margin | 18.86% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.48% | Equity United States Dividend | 206 | 0.70% | 8 | +26.54% | A2PZMV | IE00BKVKW020 |
L&G Pharma Breakthrough UCITS ETF | 2.66% | Equity World Health Care Innovation | 37 | 0.49% | 15 | +8.11% | A2H9XR | IE00BF0H7608 |
Broker | Rating | Order fee | Stock savings plans | |
---|---|---|---|---|
0.99€ | 1000 | View offer* | ||
1.00€ | 2500 | View offer* | ||
0.00€ | 2500 | View offer* | ||
0.00€ | 500 | View offer* | ||
0.00€ | 400 | View offer* |
Broker | Rating | Execution fee | Account fee | |
---|---|---|---|---|
0.00€ | 0.00€ | View offer* | ||
0.00€ | 0.00€ | View offer* | ||
1.50€ 1.50% | 0.00€ | View offer* |
YTD | +9.95% |
1 month | -5.61% |
3 months | -5.84% |
6 months | +6.21% |
1 year | +12.16% |
3 years | +37.81% |
5 years | - |
Since inception (MAX) | +26.65% |
2023 | +6.31% |
2022 | +10.31% |
2021 | - |
2020 | - |
Volatility 1 year | 16.19% |
Volatility 3 years | 18.26% |
Volatility 5 years | - |
Return per risk 1 year | 0.75 |
Return per risk 3 years | 0.62 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -12.75% |
Maximum drawdown 3 years | -14.38% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -14.38% |